Show Search Form
human indexable | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||
registered interest | |||||||||||||||||
answer date | |||||||||||||||||
date | |||||||||||||||||
date tabled | |||||||||||||||||
ddp created | |||||||||||||||||
answering body |
|
||||||||||||||||
question status | Tabled | ||||||||||||||||
answering dept id | 201 | ||||||||||||||||
answering dept short name | Business, Energy and Industrial Strategy | ||||||||||||||||
answering dept sort name | Business, Energy and Industrial Strategy | ||||||||||||||||
ddp modified |
|
||||||||||||||||
hansard heading | Avara Avlon Pharma Services: Insolvency | ||||||||||||||||
house id | 1 | ||||||||||||||||
identifier | 278449 | ||||||||||||||||
legislature |
|
||||||||||||||||
parliament number | 57 | ||||||||||||||||
question first answered |
|
||||||||||||||||
question text | To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with Astrazeneca and Avara Avlon about the (a) three year guarantee on enhanced redundancy payments and terms for staff agreed as part of the sale of the company for £1 in December 2016 and the (b) collapse of Avara Avalon. | ||||||||||||||||
session |
|
||||||||||||||||
session number | 1 | ||||||||||||||||
tabling member constituency | Newport East | ||||||||||||||||
tabling member printed |
|
||||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 278449 | ||||||||||||||||
type |
|
||||||||||||||||
uin | 278449 | ||||||||||||||||
version | 1 | ||||||||||||||||
written parliamentary question type | NamedDay | ||||||||||||||||
answer |
|
||||||||||||||||
creator |
|
||||||||||||||||
publisher |
|
||||||||||||||||
tabling member |
|